Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Feb 3;22(1):134.
doi: 10.1186/s12891-021-04017-x.

The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial

Seyed Ahmad Raeissadat  1   2 , Parsa Ghazi Hosseini  1   2 , Mohammad Hasan Bahrami  2   3 , Reza Salman Roghani  2   4 , Mohammad Fathi  5   6 , Azadeh Gharooee Ahangar  7   8 , Mahtab Darvish  1   2
Affiliations
Randomized Controlled Trial

The comparison effects of intra-articular injection of Platelet Rich Plasma (PRP), Plasma Rich in Growth Factor (PRGF), Hyaluronic Acid (HA), and ozone in knee osteoarthritis; a one year randomized clinical trial

Seyed Ahmad Raeissadat et al. BMC Musculoskelet Disord. .

Abstract

Background: Our study compare the short and long-term efficacy of the intra articular injections (IAIs) of hyaluronic acid (HA), platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), and ozone in patients with knee osteoarthritis (OA).

Methods: In this randomized clinical trial, 238 patients with mild to moderate knee OA were randomized into 4 groups of IAIs: HA (3 doses weekly), PRP (2 doses with 3 weeks interval), PRGF (2 doses with 3 weeks interval), and Ozone (3 doses weekly). Our outcome measures were the mean changes from baseline (immediately from the first injections) until 2,6, and 12 months post intervention in scores of visual analog scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Lequesne index.

Results: A total of 200 patients enrolled in the final analysis. The mean age of patients was 56.9 ± 6.3 years, and 69.5% were women. In 2 months follow up, significant improvement of pain, stiffness, and function were seen in all groups compared to the baseline, but the ozone group had the best results (P < 0.05). In 6 month follow up HA, PRP, and PRGF groups demonstrated better therapeutic effects in all scores in comparison with ozone (P < 0.05). At the end of the 12th month, only PRGF and PRP groups had better results versus HA and ozone groups in all scores (P < 0.05). Despite the fact that ozone showed better early results, its effects begin to wear off earlier than other products and ultimately disappear in 12 months.

Conclusions: Ozone injection had rapid effects and better short-term results after 2 months, but its therapeutic effects did not persist after 6 months and at the 6-month follow up, PRP,PRGF and HA were superior to ozone. Only patients in PRP and PRGF groups improved symptoms persisted for 12 months. Therefore, these products could be the preferable choices for long-term management.

Trial registration: Registered in the Iranian Center of Clinical Trials ( www.irct.ir ) in 11/11/2017 with the following code: IRCT2017082013442N17.

Keywords: Hyaluronic acid; Knee osteoarthritis; Ozone; Plasma rich in growth factor; Platelet rich plasma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Enrollment and allocation diagram
Fig. 2
Fig. 2
Bar chart of the VAS score within and between the groups at the beginning, and 2, 6 and 12 months of follow up
Fig. 3
Fig. 3
Bar chart of the WOMAC scores within and between the groups at the beginning, and 2, 6 and 12 months of follow up
Fig. 4
Fig. 4
Bar chart of the LEQ scores within and between the groups at the beginning, and 2, 6 and 12 months of follow up
See this image and copyright information in PMC

References

    1. Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg. 2011;131(3):311–317. doi: 10.1007/s00402-010-1167-3. - DOI - PubMed
    1. De La Mata J. Platelet rich plasma. A new treatment tool for the rheumatologist? Reumatología Clínica (English Edition) 2013;9(3):166–171. doi: 10.1016/j.reumae.2012.05.006. - DOI - PubMed
    1. Raeissadat SA, Rayegani SM, Sedighipour L, Bossaghzade Z, Abdollahzadeh MH, Nikray R, Mollayi F. The efficacy of electromyographic biofeedback on pain, function, and maximal thickness of vastus medialis oblique muscle in patients with knee osteoarthritis: a randomized clinical trial. J Pain Res. 2018;11:2781. doi: 10.2147/JPR.S169613. - DOI - PMC - PubMed
    1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheumatism. 2008;58(1):26–35. doi: 10.1002/art.23176. - DOI - PMC - PubMed
    1. Tehrani-Banihashemi A, Davatchi F, Jamshidi AR, Faezi T, Paragomi P, Barghamdi M. Prevalence of osteoarthritis in rural areas of I ran: a WHO-ILAR COPCORD study. Int J Rheum Dis. 2014;17(4):384–388. doi: 10.1111/1756-185X.12312. - DOI - PubMed

Publication types